| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.09 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |